Literature DB >> 5834948

The localization of radioantibodies in human brain tumors. II. Radioautography.

M S Mahaley, J L Mahaley, E D Day.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5834948

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  Membrne alterations in human glioblastoma.

Authors:  W Lubitz; A Reichert; G Birkmayer
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

2.  Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report.

Authors:  D D Bigner; M Brown; R E Coleman; A H Friedman; H S Friedman; R E McLendon; S H Bigner; X G Zhao; C J Wikstrand; C N Pegram
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

3.  Detection and assay of avian tumor virus group-specific antigen and antibody by the paired radioiodine-labeled antibody technique.

Authors:  J Weber; D S Yohn
Journal:  J Virol       Date:  1972-02       Impact factor: 5.103

4.  Tumoural antigens on experimental and human glioblastoma.

Authors:  J E Roda; J J Heredero; F J Villarejo; J M Roda
Journal:  Acta Neurochir (Wien)       Date:  1980       Impact factor: 2.216

5.  Cellular distribution of monoclonal antibody in human tumours after i.v. administration.

Authors:  V Moshakis; R A McIlhinney; A M Neville
Journal:  Br J Cancer       Date:  1981-11       Impact factor: 7.640

6.  Antigens in human glioblastomas and meningiomas: Search for tumour and onco-foetal antigens. Estimation of S-100 and GFA protein.

Authors:  L Dittmann; N H Axelsen; B Norgaard-Pedersen; E Bock
Journal:  Br J Cancer       Date:  1977-02       Impact factor: 7.640

Review 7.  Glioblastoma multiforme: State of the art and future therapeutics.

Authors:  Taylor A Wilson; Matthias A Karajannis; David H Harter
Journal:  Surg Neurol Int       Date:  2014-05-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.